Potential Savings from an Evidence‐Based Consumer‐Oriented Public Education Campaign on Prescription Drugs
- 20 September 2008
- journal article
- Published by Wiley in Health Services Research
- Vol. 43 (5p1), 1557-1575
- https://doi.org/10.1111/j.1475-6773.2008.00858.x
Abstract
To estimate potential savings associated with the Consumer Reports Best Buy Drugs program, a national educational program that provides consumers with price and effectiveness information on prescription drugs. National data on 2006 prescription sales and retail prices paid for angiotensin-converting enzyme inhibitors (ACEIs), β-blockers, calcium channel blockers, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-coA) reductase inhibitors (statins). We converted national data on aggregate unit sales of drugs in the four classes to defined daily doses (DDD) and estimated a range of potential savings from generic and therapeutic substitution. We estimated that $2.76 billion, or 7.83 percent of sales, could be saved if use of the drugs recommended by the educational program was increased. The recommended drugs' prices were 15-65 percent lower per DDD than their therapeutic alternatives. The majority (57.4 percent) of potential savings would be achieved through therapeutic substitution. Substantial savings can be achieved through greater use of comparatively effective and lower cost drugs recommended by a national consumer education program. However, barriers to dissemination of consumer-oriented drug information must be addressed before savings can be realized.Keywords
This publication has 53 references indexed in Scilit:
- The Ongoing Regulation of Generic DrugsNew England Journal of Medicine, 2007
- A Decade of Direct-to-Consumer Advertising of Prescription DrugsNew England Journal of Medicine, 2007
- Impact of Alternative Interventions on Changes in Generic Dispensing RatesHealth Services Research, 2006
- Differential Effect of Early or Late Implementation of Prior Authorization Policies on the Use of Cox II InhibitorsMedical Care, 2006
- Heart Disease and Stroke Statistics—2006 UpdateCirculation, 2006
- Underuse of ACE Inhibitors and Angiotensin II Receptor Blockers in Elderly Patients With DiabetesAmerican Journal of Kidney Diseases, 2005
- Riding The Rollercoaster: The Ups And Downs In Out-Of-Pocket Spending Under The Standard Medicare Drug BenefitHealth Affairs, 2005
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefitPharmacoepidemiology and Drug Safety, 2003
- Use Of Antihypertensive Drugs By Medicare Enrollees: Does Type Of Drug Coverage Matter?Health Affairs, 2001